Windtree Therapeutics

Biopharmaceuticals（Nasdaq:WINT)

Projets similaires

*S'il n'est pas cliquable, cela signifie qu'aucune information détaillée n'est disponible.

OSL Group

Investment holding company

The Smarter Web Company

Web Design Digital Marketing Services (AQUIS: SWC)

Linekong Interactive

Interactive entertainment and cultural enterprises

Belgravia Hartford

Investment holding and incubationCSE: BLGV

LiveOne

Digital music live streaming platform (Nasdaq: LVO)

Super Copper

Mining Exploration (CSE:CUPR)

Bitmax

Augmented reality (AR) technology development (KOSDAQ: 377030)

GameSquare Holdings Inc.

Esports and Gaming Company

A Propos de Windtree Therapeutics

Fondé

1992

Communauté

Étiquettes

Publicly listed company

Windtree Therapeutics（Nasdaq:WINT) is a clinical-stage biopharmaceutical company focused on the treatment of cardiovascular and respiratory diseases. It develops innovative drugs including Istaroxime and is achieving business transformation and financial stability through building a crypto asset treasury, diversified financing and acquisition strategies.